Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D
by Elana GotkineFor patients with heart failure and type 2 diabetes (T2D), dapagliflozin does not reduce urinary albumin-to-creatinine ratio (UACR) but does reduce some cardiovascular events, accordin
Updated on: January 26,2024
13

Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D
by Elana GotkineFor patients with heart failure and type 2 diabetes (T2D), dapagliflozin does not reduce urinary albumin-to-creatinine ratio (UACR) but does reduce some cardiovascular events, accordin
Updated on:January 26,2024
13
